6-K
UTime Ltd (FXHO)
UNITEDSTATES
SECURITIESAND EXCHANGE COMMISSION
Washington,D.C. 20549
FORM6-K
REPORTOF FOREIGN PRIVATE ISSUER
PURSUANTTO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIESEXCHANGE ACT OF 1934
For the Month of October 2025
Commission file number 001-40306
UTIMELIMITED
7^th^Floor Building 5A
ShenzhenSoftware Industry Base
Nanshan,Shenzhen
People’sRepublic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
INFORMATIONCONTAINED IN THIS FORM 6-K REPORT
On October 30, 2025, UTime Limited (the “Company”) issued a press release announcing the release of its smart ring product. A copy of the press release is attached hereto as Exhibit 99.1.
ExhibitIndex
| Exhibit<br> No. | Description |
|---|---|
| 99.1 | Press Release dated October 30, 2025. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| UTIME LIMITED | ||
|---|---|---|
| Dated: October 30, 2025 | By: | /s/ Hengcong Qiu |
| Name: | Hengcong Qiu | |
| Title: | Chief Executive Officer | |
| (Principal Executive Officer) |
Exhibit99.1
UTimeLimited Releases Smart Ring, Focusing on Sleep and Continuous Health Monitoring
SHENZHEN,China, October 30 2025 – UTime Limited (Nasdaq: WTO) today released its smart ring product. Utilizing the advantage of unnoticeable wear, the product aims to provide users with nighttime and long-term continuous health data monitoring.
This smart ring features a precise and compact design, capable of monitoring multiple physiological parameters including skin temperature, blood oxygen saturation (SpO2), respiratory rate, and heart rate variability (HRV). Its key application scenario is sleep quality assessment, aiming to generate more detailed sleep analysis reports by collecting data unobtrusively during user sleep. Additionally, the product focuses on daily activity tracking and female health cycle management, offering users more comprehensive health insights.
Mr. Hengcong Qiu, Chief Executive Officer of UTime Limited, stated, “We believe the smart ring form factor is an important addition to the health wearable device market. It addresses user needs for continuous, unnoticeable monitoring in specific scenarios, complementing smartwatches effectively.”
AboutUTime Limited
Trading under the NASDAQ ticker WTO, UTime Limited is engaged in the design, development, production, sales and brand operation of mobile devices in China and globally. The company aims to provide cost-effective products and serves a broad customer base.
SafeHarbor Statement
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. For additional risk factors, please review UTime Limited’s Annual Report on Form 20-F and other SEC filings. Forward-looking statements are made only as of the date of this release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required under applicable law.
Contact:
UTime Limited
7th Floor, Building 5A
Shenzhen Software Industry Base, Nanshan District
Shenzhen, People’s Republic of China 518061
Tel: (86) 755 86512266